BPC-157 works primarily through angiogenesis promotion, nitric oxide modulation, and growth factor expression
In its full extent, the range of BPC 157 therapy and its huge curing potential as a treatment (for review, see [1,3,4,5,6,8,9,32,33,34,92]) might largely override the range of the beneficial effects commonly reported with standard cytoprotective agents (for review, see [35,36,37,38,39,40,41,42]) (i.e., prostaglandins beneficial effects on the stomach [35], intestine [38], liver [130], pancreas [39], kidney [38,131], and heart [132])
Older adults over the age of 60 because the stomach lining produces less stomach acid as we age which is needed to absorb B12
Started with 0.25 mg subcutaneous injections daily, about two inches from the burn site